<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02165787</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-2014-0004/PB_2016-00386</org_study_id>
    <nct_id>NCT02165787</nct_id>
  </id_info>
  <brief_title>Investigation of Gait Parameters in Health and Neurological Disease Under Varying Locomotor Conditions</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the cross-sectional component of this study, our overall objective is to gather a large&#xD;
      pool of data from which we can generate gait &quot;profiles&quot;. These profiles will consist of a&#xD;
      constellation of gait (+/- electrophysiological) parameters associated with a particular&#xD;
      neurological diagnosis or specific lesion(s) in neuroanatomical systems. Once developed,&#xD;
      these profiles can be compared for differences and similarities; allowing insights into the&#xD;
      specificity of the effect on gait of a given diagnosis or lesion in the case of the former&#xD;
      and redundancy of neuroanatomical systems in that of the latter. A longitudinal component of&#xD;
      the study will look at the evolution of gait parameters over time in a group of patients with&#xD;
      spinal cord injury.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of gait parameter after injury to CNS</measure>
    <time_frame>Timepoint 0 plus timepoint 6 months and 12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Gait Analysis in Neurological Disorders</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy control subjects</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients aged 18-80 with spinal cord injury, hemispheric stroke, multiple sclerosis,&#xD;
        Parkinson disease, vestibular disease, cerebellar disease. Healthy control subjects aged&#xD;
        18-80.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  age 18 - 80&#xD;
&#xD;
          -  written, informed consent&#xD;
&#xD;
          -  one of the following established diagnoses: unilateral stroke affecting motor system,&#xD;
             Parkinson syndrome, cerebellar disease, vestibular dysfunction, spinal cord injury,&#xD;
             multiple sclerosis&#xD;
&#xD;
          -  Brain and whole spine T1, T2 &amp; FLAIR magnetic resonance imaging performed within the&#xD;
             last four months and available for study purposes or no contraindications to&#xD;
             performing these scans&#xD;
&#xD;
        Healthy subjects:&#xD;
&#xD;
          -  age 18 - 80&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Colour-blindness&#xD;
&#xD;
          -  Known to be pregnant or breastfeeding&#xD;
&#xD;
          -  Body mass index (weight in kg/height in metres squared) &gt;40 Unable to walk 50m within&#xD;
             6 minutes (with or without walking aids) Inability to undertake any component of the&#xD;
             trial protocol&#xD;
&#xD;
          -  Terminal diagnosis with life expectancy less than six months&#xD;
&#xD;
          -  Cognitive disturbance defined as MMSE &lt; 25 Clinically significant comorbidities such&#xD;
             as severe cardiovascular, pulmonary or malignant disease&#xD;
&#xD;
        Healthy subjects:&#xD;
&#xD;
          -  Colour-blindness&#xD;
&#xD;
          -  Known to be pregnant or breastfeeding&#xD;
&#xD;
          -  Body mass index (weight in kg/height in metres squared) &gt;40 Unable to walk 50m within&#xD;
             6 minutes&#xD;
&#xD;
          -  Reliance on walking aids / prostheses for mobilisation&#xD;
&#xD;
          -  Significant neurological or orthopaedic diagnosis with potential impact on gait //&#xD;
             Previous operations on the lower limbs or spine with potential impact on gait&#xD;
             Inability to undertake any component of the trial protocol Clinically significant&#xD;
             conditions such as severe cardiovascular, pulmonary or malignant disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Bolliger, PD</last_name>
    <phone>+41 44 510 72 01</phone>
    <email>marc.bolliger@balgrist.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armin Curt, MD</last_name>
      <phone>+41 44 386 39 01</phone>
      <email>armin.curt@balgrist.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Killeen T, Easthope CS, Filli L, Linnebank M, Curt A, Bolliger M, Zörner B. Modulating Arm Swing Symmetry with Cognitive Load: A Window on Rhythmic Spinal Locomotor Networks in Humans? J Neurotrauma. 2017 May 15;34(10):1897-1902. doi: 10.1089/neu.2016.4554. Epub 2016 Oct 12.</citation>
    <PMID>27574966</PMID>
  </reference>
  <reference>
    <citation>Killeen T, Easthope CS, Filli L, Lőrincz L, Schrafl-Altermatt M, Brugger P, Linnebank M, Curt A, Zörner B, Bolliger M. Increasing cognitive load attenuates right arm swing in healthy human walking. R Soc Open Sci. 2017 Jan 25;4(1):160993. doi: 10.1098/rsos.160993. eCollection 2017 Jan.</citation>
    <PMID>28280596</PMID>
  </reference>
  <reference>
    <citation>Filli L, Meyer C, Killeen T, Lörincz L, Göpfert B, Linnebank M, von Tscharner V, Curt A, Bolliger M, Zörner B. Probing Corticospinal Control During Different Locomotor Tasks Using Detailed Time-Frequency Analysis of Electromyograms. Front Neurol. 2019 Jan 29;10:17. doi: 10.3389/fneur.2019.00017. eCollection 2019.</citation>
    <PMID>30761064</PMID>
  </reference>
  <reference>
    <citation>Killeen T, Easthope CS, Demkó L, Filli L, Lőrincz L, Linnebank M, Curt A, Zörner B, Bolliger M. Minimum toe clearance: probing the neural control of locomotion. Sci Rep. 2017 May 15;7(1):1922. doi: 10.1038/s41598-017-02189-y.</citation>
    <PMID>28507300</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>June 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2014</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

